Medications and Pharmacological Fitness Evaluation Flashcards

Under 49 CFR 391.41(b)(12), a driver is using a Schedule I controlled substance in a state where it is legally permitted for medical use. What is the correct certification decision?

Answer: Disqualify the driver; federal law prohibits Schedule I substance use regardless of state law or medical justification

Federal DOT regulations (49 CFR 391.41(b)(12)) prohibit CMV drivers from using any Schedule I substance. Federal law supersedes state law in this context, and no physician letter exception applies to Schedule I substances—that exception is limited to lawfully prescribed medications in schedules other than Schedule I.

A driver is prescribed a narcotic analgesic by a licensed physician who is aware of the driver's CMV duties and has provided a letter stating the driver can safely operate a commercial vehicle while on this medication. What must the medical examiner do?

Answer: Use professional judgment—the physician letter permits but does not require the ME to certify

The regulatory exception in 49 CFR 391.41(b)(12) allows a medical examiner to certify a driver on a prescribed narcotic if a licensed medical practitioner who knows the driver operates a CMV provides a statement that the driver can safely operate. However, this permits but does not compel the ME to certify—the ME retains independent clinical judgment.

Which of the following medications is LEAST likely to affect a driver's CMV medical certification when used as prescribed?

Answer: Metformin for type 2 diabetes

Metformin is a non-sedating oral antidiabetic medication that does not impair alertness, reaction time, or cognitive function. FMCSA guidance does not restrict its use for CMV drivers. Benzodiazepines, opioids (tramadol), and sedative-hypnotics (zolpidem) all carry CNS depression risks and are subject to much more careful scrutiny.

A driver taking an antiepileptic medication asks to be certified. The driver has been seizure-free for two years on the medication. What is the most appropriate action under FMCSA standards?

Answer: Evaluate seizure-free history against federal exemption program requirements before certifying

FMCSA regulations disqualify drivers with a seizure disorder unless they qualify under the federal seizure exemption program, which requires an extended seizure-free period. The fact that a driver is taking antiepileptic medication indicates an underlying seizure disorder; two years seizure-free does not automatically meet the federal exemption threshold, and certification requires exemption approval.

FMCSA advisory criteria indicate that which class of medications poses the greatest concern for CMV driver safety due to sedation, impaired reaction time, and fall risk?

Answer: Benzodiazepines and other CNS depressants

Benzodiazepines and other CNS depressants are flagged in FMCSA advisory criteria and Medical Review Board recommendations as posing significant safety risks for CMV drivers due to sedation, cognitive slowing, and impaired psychomotor function. FMCSA's Medical Expert Panel has recommended that individuals currently using benzodiazepines generally should not be cleared to drive a CMV.

A driver reports taking an over-the-counter antihistamine (diphenhydramine) nightly for sleep. How should the medical examiner respond?

Answer: Discuss the sedating effects and safety risks and assess whether use impairs CMV driving fitness

The ME must review all medications, including OTC drugs, and counsel the driver on potential hazards. Diphenhydramine has significant sedating and anticholinergic effects that can carry over into daytime driving. While not automatically disqualifying, the ME must evaluate whether its use impairs the driver's ability to safely operate a CMV and document the discussion.